CAS: 2130996-00-6
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | GLPG2938 REF: IN-DA01X7A2CAS: 2130996-00-6 | 97% | 195,00 €~525,00 € | Mar 10 Dic 24 |
 | GLPG2938 REF: TM-T9199CAS: 2130996-00-6 | 98.25% | 83,00 €~1.079,00 € | Lun 16 Dic 24 |
 | GLPG2938 REF: 3D-FKD99600CAS: 2130996-00-6 | Min. 95% | A consultar | Mar 21 Ene 25 |
Ref: IN-DA01X7A2
| 25mg | 195,00 € | ||
| 50mg | 328,00 € | ||
| 100mg | 525,00 € |
Entrega estimada en Estados Unidos, el Martes 10 de Diciembre de 2024
GLPG2938
CAS:2130996-00-6
GLPG2938 (1-(2-Ethoxy-6-(trifluoromethyl)pyridin-4-yl)-3-((5-methyl-6-(1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl)pyridazin-3-yl)methyl)urea) is a potent and
Fórmula:
C20H19F6N7O2
Pureza:
98.25%
Forma y color:
Solid
Peso molecular:
503.4
Ref: TM-T9199
| 1mg | 83,00 € | ||
| 5mg | 159,00 € | ||
| 10mg | 271,00 € | ||
| 25mg | 542,00 € | ||
| 50mg | 782,00 € | ||
| 100mg | 1.079,00 € | ||
| 1mL*10mM (DMSO) | 168,00 € |
Entrega estimada en Estados Unidos, el Lunes 16 de Diciembre de 2024
GLPG2938
CAS:2130996-00-6
GLPG2938 is a small molecule inhibitor of the extracellular, membrane-bound form of the human insulin …
Fórmula:
C20H19F6N7O2
Pureza:
Min. 95%
Peso molecular:
503.40 g/mol
Ref: 3D-FKD99600
| 50mg | A consultar | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 21 de Enero de 2025
